# Redmed Inc – FDA Inspection, Dec 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/redmed-inc/a5ed1e17-f0f3-442d-a3ee-a2039cf000df
Source feed: FDA_Inspections

> FDA inspection 1258018 of Redmed Inc, December 12, 2024. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1258018
- Company Name: Redmed Inc
- Inspection Date: 2024-12-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1098290 - 2019-06-24
- FDA Inspection 867835 - 2014-02-24
- FDA Inspection 685683 - 2010-10-19

## Related Officers

- [Company Rep](https://www.keypedia.com/people/maira-p-brading/892072f4-e584-48d1-890c-e0a47dfbdffa)

Company: https://www.keypedia.com/companies/redmed-inc/ae44343f-7e85-4c02-850f-8c87234945ee

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d